by Scott Larrivee | Dec 29, 2025 | Blog
Shakespeare said the past is prologue. In that spirit, we submit this look back at 2025. It’s been a year of tremendous progress at Nusano. Our teams are working to enable fields ranging from healthcare to nuclear energy. Every step of the way, we are guided by...
by Scott Larrivee | Jun 19, 2025 | News
Alpha-emitting radioisotope expected to play an essential role in next-generation targeted cancer therapies DURHAM, N.C. and WEST VALLEY CITY, Utah – June 19, 2025 – dGenThera, Inc., a biotechnology company pioneering theranostic molecular pairs, and Nusano, a...
